Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -75.09%-18.29M | -24.87%-6.56M | -150.93%-1.89M | 27.06%-21.14M | 13.88%-4.69M | 38.82%-10.44M | -20.95%-5.26M | 64.54%-754.05K | -47.43%-28.99M | -61.06%-5.45M |
| Net income from continuing operations | -55.44%-13.97M | -28.59%-9.29M | -4.09%-2.34M | 22.52%-20.65M | 44.97%-2.19M | 34.04%-8.98M | -9.27%-7.22M | 7.63%-2.25M | -38.30%-26.65M | -52.79%-3.98M |
| Operating gains losses | --0 | --0 | --5.09K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -21.70%9.17K | -31.66%9.17K | -18.26%9.06K | -12.45%48.06K | -14.07%11.85K | -15.08%11.71K | -4.86%13.42K | -16.10%11.08K | -11.42%54.89K | -16.82%13.79K |
| Remuneration paid in stock | -4.60%529.08K | -53.54%532.2K | 72.20%600.47K | 31.98%2.6M | 14.88%552.02K | 18.19%554.61K | 136.38%1.15M | -34.97%348.71K | 10.37%1.97M | 55.93%480.53K |
| Deferred tax | --19.93K | --157.76K | --128.77K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cashItems | -30.46%-2.96M | ---1.14M | ---58.92K | -17.59%-4.3M | -9,756.72%-398.31K | 4.18%-2.27M | ---- | ---- | -51.49%-3.66M | 80.57%-4.04K |
| Change In working capital | -876.28%-1.91M | 29.94%3.16M | -120.46%-232.82K | 264.07%1.16M | -36.41%-2.66M | 115.81%246.68K | -17.54%2.44M | 876.29%1.14M | -501.75%-705.17K | -81.14%-1.95M |
| -Change in receivables | -432.41%-1.33M | -92.48%-367.08K | -102.06%-16.16K | 207.76%899.71K | 425.95%554.18K | 45.75%-249.81K | 17.40%-190.71K | 2,867.55%786.04K | -2,230.41%-834.92K | -135.56%-170.02K |
| -Change in prepaid assets | -27.45%185.37K | -415.36%-674.23K | 101.55%956 | 160.30%140.17K | -46.82%77.13K | 16.69%255.5K | 67.42%-130.83K | 68.37%-61.63K | -555.72%-232.46K | 25.19%145.04K |
| -Change in payables and accrued expense | -419.63%-770.26K | 54.33%4.26M | -152.63%-217.62K | -67.66%117.13K | -70.93%-3.29M | 118.28%240.99K | -23.12%2.76M | 1,797.94%413.5K | 46.76%362.21K | -15.29%-1.93M |
| -Change in other working capital | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -75.09%-18.29M | -24.87%-6.56M | -150.93%-1.89M | 27.06%-21.14M | 13.88%-4.69M | 38.82%-10.44M | -20.95%-5.26M | 64.54%-754.05K | -47.43%-28.99M | -61.06%-5.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3.43K | 130,230.75%17.93M | -223,803.82%-16.05M | -16,126.87%-2.29M | -227,272,200.00%-2.27M | 0 | -156.90%-13.78K | 18.30%-7.17K | 99.77%-14.14K | 100.02%1 |
| Net PPE purchase and sale | ---3.43K | -1,578.94%-231.36K | 47.48%-3.76K | -1,128.98%-173.72K | -15,277,000.00%-152.77K | --0 | -156.90%-13.78K | 18.30%-7.17K | 99.77%-14.14K | 100.02%1 |
| Net investment purchase and sale | --0 | --18.16M | ---16.04M | ---2.12M | ---2.12M | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---3.43K | 130,230.75%17.93M | -223,803.82%-16.05M | -16,126.87%-2.29M | -227,272,200.00%-2.27M | --0 | -156.90%-13.78K | 18.30%-7.17K | 99.77%-14.14K | 100.02%1 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.13%264.2K | 6,461.13%26.88M | -99.00%139.65K | 333.92%45.51M | -92.21%773.77K | 30.36M | 88.49%409.65K | 4,043.20%13.97M | -73.05%10.49M | -53.25%9.93M |
| Net common stock issuance | -100.25%-75.49K | 655,760.63%26.86M | -100.19%-25.91K | 345.06%44.19M | -100.12%-12.24K | --30.24M | ---4.1K | 344,151.03%13.97M | -74.25%9.93M | -53.04%9.93M |
| Proceeds from stock option exercised by employees | 199.03%339.69K | -96.26%15.46K | 2,548.99%165.56K | 136.05%1.32M | 221,311.55%786.01K | --113.6K | 90.38%413.75K | -98.17%6.25K | 59.71%559.04K | -99.63%355 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.13%264.2K | 6,461.13%26.88M | -99.00%139.65K | 333.92%45.51M | -92.21%773.77K | --30.36M | 88.49%409.65K | 4,043.20%13.97M | -73.05%10.49M | -53.25%9.93M |
| Net cash flow | ||||||||||
| Beginning cash position | 186.35%52.5M | -38.53%14.26M | 221.14%32.06M | -64.97%9.98M | 596.19%38.25M | -18.74%18.34M | -13.12%23.2M | -64.97%9.98M | 84.08%28.5M | -48.34%5.49M |
| Current changes in cash | -190.53%-18.03M | 886.90%38.25M | -234.71%-17.8M | 219.24%22.08M | -237.88%-6.19M | 216.64%19.91M | -17.58%-4.86M | 834.86%13.21M | -242.24%-18.51M | -74.87%4.49M |
| End cash Position | -9.85%34.48M | 186.35%52.5M | -38.53%14.26M | 221.14%32.06M | 221.14%32.06M | 596.19%38.25M | -18.74%18.34M | -13.12%23.2M | -64.97%9.98M | -64.97%9.98M |
| Free cash from | -75.13%-18.29M | -28.93%-6.79M | -149.06%-1.9M | 26.49%-21.32M | 11.07%-4.84M | 38.82%-10.44M | -21.12%-5.27M | 64.35%-761.21K | -11.96%-29M | -60.75%-5.45M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.